arrow
J

Jeffrey W. Craig

University of Virginia
H指数:23
被引数:3,104

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combating CD24 to overcome CD19 CAR-T resistance via induction of innate and adaptive immunity in B-cell malignancies

通过诱导先天性和适应性免疫来对抗CD24,以克服B细胞恶性肿瘤中CD19 CAR-T的耐药性

Leukemia
IF13.4
2026-10-120
OAAI
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma

LySeqST:一种用于弥漫性大B细胞淋巴瘤稳健基因组分类的靶向测序检测方法

2026-04-170
OAAI
The C/EBPα–(PU.1–LOUP) regulatory circuit regulates monocyte/macrophage development and immune functions

C/EBPα–(PU.1–LOUP)调控环路调控单核细胞/巨噬细胞发育和免疫功能

Blood
IF23.1
2026-01-290
PRE
Population-Wide Introduction of Dose-Adjusted EPOCH-R In High-grade B-cell Lymphoma with MYC/BCL2 Rearrangements, DLBCL Morphology

在高MYC/BCL2易位的弥漫大B细胞淋巴瘤中,进行剂量调整的EPOCH-R方案的群体推广,该淋巴瘤具有DLBCL形态。

2025-10-170
OAAI
Nanoromidepsin, a Polymer Nanoparticle of the HDAC Inhibitor, Improves Safety and Efficacy in Models of T-cell Lymphoma

Nanoromidepsin,一种HDAC抑制剂的聚合物纳米颗粒,在T细胞淋巴瘤模型中提高了安全性和有效性。

Blood
IF23.1
2025-09-040
PRE
Phase II study of venetoclax added to bendamustine and obinutuzumab in patients with high-risk follicular lymphoma as front-line therapy: PrE0403

II期研究:将venetoclax加入bendamustine和obinutuzumab用于高风险滤泡性淋巴瘤患者的一线治疗:PrE0403

2025-05-120
OA
Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk
2022-11-0914
OAAI
Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach

局限性结节性淋巴细胞为主的霍奇金淋巴瘤的结局以及PET适应方法的影响

2021-09-246
OA
Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia
LEUKEMIA
IF13.4
2020-02-1730
OAAI